Cell line · CVCL_RG45
CHO EOT-3
Spontaneously immortalized cell line, Cricetulus griseus. 4 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. CHO EOT-3. Cell lines, record CVCL_RG45. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_RG45
On this page
Cell line
As Cellosaurus gives it.
- Name
- CHO EOT-3
- Accession
- CVCL_RG45
- RRID
- RRID:CVCL_RG45
- Synonyms
- EOT-3, EOT, PEOT, Pro-Emt(rI)Emt(rII)Oua(R)Thg(r), Emetine Ouabain Thioguanine resistant-3
- Species
- Cricetulus griseus (Chinese hamster)
- Sex
- Female
- Age at sampling
- Adult
- Category
- Spontaneously immortalized cell line
- Derived from
- Ovary (in situ)
- Cell type
- Epithelial cell of ovary
- Parent
- CHO Pro-3 (CVCL_7182)
- Entry created
- 2018-03-05
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers4
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Novel mutants of CHO cells resistant to adenosine analogs and containing biochemically altered form of adenosine kinase in cell extracts. | Somat Cell Mol Genet | 1986 | Cellosaurus cites it | PubMed | |
| Formycin B-resistant mutants of Chinese hamster ovary cells: novel genetic and biochemical phenotype affecting adenosine kinase. | Mol Cell Biol | 1983 | Cellosaurus cites it | PubMed | |
| Evidence for functional hemizygosity at the Emtr locus in CHO cells through segregation analysis. | Cell | 1978 | Cellosaurus cites it | PubMed | |
| Genetic and biochemical studies with the adenosine analogs toyocamycin and tubercidin: mutation at the adenosine kinase locus in Chinese hamster cells. | Somatic Cell Genet | 1978 | Cellosaurus cites it | PubMed |
Relatives4
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | CHO Pro-3 | CVCL_7182 | Cell lines | |
| Derived from it | CHO EOT-Toyr-2 | CVCL_F0DK | Cell lines | |
| Derived from it | CHO EOT-Toyr-6 | CVCL_F0F1 | Cell lines | |
| Derived from it | CHO EOTMA | CVCL_F0F2 | Cell lines |
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_RG45
GET https://conductscience.org/api/cell-lines/v1/CVCL_RG45/problems